Literature DB >> 7644108

R-HuEPO hyporesponsiveness--who and why?

T B Drüeke1.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7644108     DOI： 10.1093/ndt/10.supp2.62

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  9 in total

1.  The importance of serum transferrin receptor level in the diagnosis of functional iron deficiency due to recombinant human erythropoietin treatment in haemodialysis patients.

Authors:  H Z Tonbul; H Kaya; N Y Selçuk; S B Tekin; A San; F Akçay; E Akarsu
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

2.  Long-term effects of oral L-carnitine supplementation on anemia in chronic hemodialysis.

Authors:  Yasuo Kudoh; Shinya Aoyama; Takaaki Torii; Qijie Chen; Daigo Nagahara; Hiromi Sakata; Akihiko Nozawa
Journal:  Cardiorenal Med       Date:  2014-03-21       Impact factor: 2.041

3.  Elderly patients on chronic hemodialysis with hyperparathyroidism: increase of hemoglobin level after intravenous calcitriol.

Authors:  Pedro L Neves; Julio Triviño; Francisco Casaubon; Viriato Santos; Patricia Mendes; Paulo Romão; Isilda Bexiga; Idalécio Bernardo
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

4.  Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy.

Authors:  Elísio Costa; Margarida Lima; João Moura Alves; Susana Rocha; Petronila Rocha-Pereira; Elisabeth Castro; Vasco Miranda; Sameiro Faria Maria do; Alfredo Loureiro; Alexandre Quintanilha; Luís Belo; Alice Santos-Silva
Journal:  J Clin Immunol       Date:  2008-05       Impact factor: 8.317

Review 5.  Epoetin alfa. A review of its clinical efficacy in the management of anaemia associated with renal failure and chronic disease and its use in surgical patients.

Authors:  C J Dunn; A J Wagstaff
Journal:  Drugs Aging       Date:  1995-08       Impact factor: 3.923

6.  Elderly patients on chronic hemodialysis: effect of the secondary hyperparathyroidism on the hemoglobin level.

Authors:  Pedro L Neves; Julio Triviño; Francisco Casaubon; Paulo Romão; Patricia Mendes; Isilda Bexiga; Isabel Pinto; Viriato Santos; Idalécio Bernardo
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

7.  Factors related to erythropoietin hypo-responsiveness in patients on chronic peritoneal dialysis.

Authors:  Mingxin Wei; Joanne M Bargman; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2007-05-30       Impact factor: 2.370

8.  Impact of diabetes on haemoglobin levels in renal disease.

Authors:  R Ravanan; J R Spiro; P W Mathieson; R M Smith
Journal:  Diabetologia       Date:  2006-11-28       Impact factor: 10.122

9.  Advanced glycosylation end products (AGEs), insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) in patients with type 2 diabetes mellitus.

Authors:  M E Garay-Sevilla; L E Nava; J M Malacara; K Wróbel; K Wróbel; U Pérez
Journal:  Diabetes Metab Res Rev       Date:  2000 Mar-Apr       Impact factor: 8.128
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.